DELX (Delex Healthcare Group) EBITDA Margin %: 0.00% (As of Sep. 2023)


What is Delex Healthcare Group EBITDA Margin %?

Delex Healthcare Group DELX EBITDA Margin % is 0.00% as of Sep. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Delex Healthcare Group's EBITDA for the six months ended in Sep. 2023 was $0.00 Mil. Delex Healthcare Group's Revenue for the six months ended in Sep. 2023 was $0.00 Mil. Therefore, Delex Healthcare Group's EBITDA margin for the quarter that ended in Sep. 2023 was 0.00%.

Delex Healthcare Group  (OTCPK:DELX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Delex Healthcare Group EBITDA Margin % Related Terms

Delex Healthcare Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Delex Healthcare Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delex Healthcare Group EBITDA Margin % Chart

Delex Healthcare Group Annual Data
Trend
EBITDA Margin %

Delex Healthcare Group Semi-Annual Data
Sep22 Sep23
EBITDA Margin % 0.00 0.00

DELX vs PIAC, PWM, BHV: EBITDA Margin % Comparison

For the Drug Manufacturers - General subindustry, Delex Healthcare Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delex Healthcare Group EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delex Healthcare Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Delex Healthcare Group's EBITDA Margin % falls into.


Delex Healthcare Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Delex Healthcare Group's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Delex Healthcare Group's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Delex Healthcare Group (DELX) has a EBITDA Margin % of 0.00% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Delex Healthcare Group and its competitors.
Is Delex Healthcare Group's EBITDA Margin % too high?
Delex Healthcare Group's current EBITDA Margin % is 0.00%.
How does Delex Healthcare Group's EBITDA Margin % compare to PIAC and PWM?
Delex Healthcare Group's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Delex Healthcare Group and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delex Healthcare Group's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delex Healthcare Group stock overvalued right now?
Delex Healthcare Group (DELX) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Delex Healthcare Group (DELX), the current EBITDA Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delex Healthcare Group Business Description

Address Carnation Street, Blk 4, Lot 4, Cor., Magnolia, Novaliches, Quezon City, PHL, 1109
Delex Healthcare Group Inc is a healthcare-focused organization engaged in pharmaceutical and healthcare-related businesses.